is semaglutide bad for your heart GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% Frontiers | Safety of Semaglutide
Description
For some people, weeks 3 and 4 bring a slight reduction in the appetite-suppressing effect compared to week 1

[DOI] [PMC free article] [PubMed] [Google Scholar] 250.Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW

Novo Nordisk, the maker of Ozempic, Rybelsus and Wegovy, said in a statement to CBS News: "It's important that patients are aware that Novo Nordisk is the only company in the U.S

Do not buy weight-loss medicines from unregulated sources

This is so great that research is showing the positive impacts of this medication in a time when many are starting to lose access to it